The role of platelets in peripheral vascular disease

Kevin Cassar, P. Bachoo, Julie Brittenden

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Abstract: Platelets play a major role in acute ischaemic syndromes and peripheral vascular disease. They are involved in the development and progression of atherosclerosis, native vessel and graft thrombosis. They have a central role in the development of restenosis and reocclusion after peripheral percutaneous transluminal angioplasty. Antiplatelet therapy has been shown to be beneficial in patients undergoing peripheral vascular surgery or radiological intervention. Yet current routine therapy, namely aspirin and dipyridamole are limited in their mode of action and efficacy. Recent developments in the understanding of platelet function has led to the development of new more potent drugs such as clopidogrel. Combination of drugs and more specific investigation of individual platelet function may well result in improved bypass and angioplasty patency rates. The results of proposed large randomised controlled trials on the role and safety of aspirin and clopidogrel are awaited with interest. Given the importance of platelets in peripheral vascular disease highlighted in this review, achieving an optimal safe anti-platelet effect for each patient with peripheral vascular disease should be the target of future research.

Original languageEnglish
Pages (from-to)6-15
Number of pages10
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume25
Issue number1
DOIs
Publication statusPublished - Jan 2003

Keywords

  • platelets
  • platelet activation
  • occlusive disease
  • coagulatory activity
  • hemostatic factors
  • IIIA
  • fibrinogen
  • GMP-140
  • events
  • risk
  • platelet aggregation
  • peripheral vascular diseases
  • angioplasty
  • platelet aggregation inhibitors
  • percutaneous transluminal angioplasty
  • human atherosclerotic plaques
  • lower-extremity bypass
  • baboon exvivo shunt
  • smooth-muscle cell
  • growth-factor
  • diabetes-mellitus
  • nitric-oxide
  • vonwillebrand-factor
  • balloon angioplasty

Cite this

The role of platelets in peripheral vascular disease. / Cassar, Kevin; Bachoo, P.; Brittenden, Julie.

In: European Journal of Vascular and Endovascular Surgery, Vol. 25, No. 1, 01.2003, p. 6-15.

Research output: Contribution to journalArticle

@article{7eb842b42a004ffeb322b939decb6258,
title = "The role of platelets in peripheral vascular disease",
abstract = "Abstract: Platelets play a major role in acute ischaemic syndromes and peripheral vascular disease. They are involved in the development and progression of atherosclerosis, native vessel and graft thrombosis. They have a central role in the development of restenosis and reocclusion after peripheral percutaneous transluminal angioplasty. Antiplatelet therapy has been shown to be beneficial in patients undergoing peripheral vascular surgery or radiological intervention. Yet current routine therapy, namely aspirin and dipyridamole are limited in their mode of action and efficacy. Recent developments in the understanding of platelet function has led to the development of new more potent drugs such as clopidogrel. Combination of drugs and more specific investigation of individual platelet function may well result in improved bypass and angioplasty patency rates. The results of proposed large randomised controlled trials on the role and safety of aspirin and clopidogrel are awaited with interest. Given the importance of platelets in peripheral vascular disease highlighted in this review, achieving an optimal safe anti-platelet effect for each patient with peripheral vascular disease should be the target of future research.",
keywords = "platelets, platelet activation, occlusive disease, coagulatory activity, hemostatic factors, IIIA, fibrinogen, GMP-140, events, risk, platelet aggregation, peripheral vascular diseases, angioplasty, platelet aggregation inhibitors, percutaneous transluminal angioplasty, human atherosclerotic plaques, lower-extremity bypass, baboon exvivo shunt, smooth-muscle cell, growth-factor, diabetes-mellitus, nitric-oxide, vonwillebrand-factor , balloon angioplasty",
author = "Kevin Cassar and P. Bachoo and Julie Brittenden",
year = "2003",
month = "1",
doi = "10.1053/ejvs.2002.1795",
language = "English",
volume = "25",
pages = "6--15",
journal = "European Journal of Vascular and Endovascular Surgery",
issn = "1078-5884",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The role of platelets in peripheral vascular disease

AU - Cassar, Kevin

AU - Bachoo, P.

AU - Brittenden, Julie

PY - 2003/1

Y1 - 2003/1

N2 - Abstract: Platelets play a major role in acute ischaemic syndromes and peripheral vascular disease. They are involved in the development and progression of atherosclerosis, native vessel and graft thrombosis. They have a central role in the development of restenosis and reocclusion after peripheral percutaneous transluminal angioplasty. Antiplatelet therapy has been shown to be beneficial in patients undergoing peripheral vascular surgery or radiological intervention. Yet current routine therapy, namely aspirin and dipyridamole are limited in their mode of action and efficacy. Recent developments in the understanding of platelet function has led to the development of new more potent drugs such as clopidogrel. Combination of drugs and more specific investigation of individual platelet function may well result in improved bypass and angioplasty patency rates. The results of proposed large randomised controlled trials on the role and safety of aspirin and clopidogrel are awaited with interest. Given the importance of platelets in peripheral vascular disease highlighted in this review, achieving an optimal safe anti-platelet effect for each patient with peripheral vascular disease should be the target of future research.

AB - Abstract: Platelets play a major role in acute ischaemic syndromes and peripheral vascular disease. They are involved in the development and progression of atherosclerosis, native vessel and graft thrombosis. They have a central role in the development of restenosis and reocclusion after peripheral percutaneous transluminal angioplasty. Antiplatelet therapy has been shown to be beneficial in patients undergoing peripheral vascular surgery or radiological intervention. Yet current routine therapy, namely aspirin and dipyridamole are limited in their mode of action and efficacy. Recent developments in the understanding of platelet function has led to the development of new more potent drugs such as clopidogrel. Combination of drugs and more specific investigation of individual platelet function may well result in improved bypass and angioplasty patency rates. The results of proposed large randomised controlled trials on the role and safety of aspirin and clopidogrel are awaited with interest. Given the importance of platelets in peripheral vascular disease highlighted in this review, achieving an optimal safe anti-platelet effect for each patient with peripheral vascular disease should be the target of future research.

KW - platelets

KW - platelet activation

KW - occlusive disease

KW - coagulatory activity

KW - hemostatic factors

KW - IIIA

KW - fibrinogen

KW - GMP-140

KW - events

KW - risk

KW - platelet aggregation

KW - peripheral vascular diseases

KW - angioplasty

KW - platelet aggregation inhibitors

KW - percutaneous transluminal angioplasty

KW - human atherosclerotic plaques

KW - lower-extremity bypass

KW - baboon exvivo shunt

KW - smooth-muscle cell

KW - growth-factor

KW - diabetes-mellitus

KW - nitric-oxide

KW - vonwillebrand-factor

KW - balloon angioplasty

U2 - 10.1053/ejvs.2002.1795

DO - 10.1053/ejvs.2002.1795

M3 - Article

VL - 25

SP - 6

EP - 15

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

SN - 1078-5884

IS - 1

ER -